More than half (55%) of eligible Medicare beneficiaries are enrolled in Medicare Advantage in 2026. To better understand trends in the growth of the Medicare Advantage program, this brief provides current information about enrollment, including by plan type and firm
This brief provides information about Medicare Advantage plans in 2026, including premiums, out-of-pocket limits, supplemental benefits, and prior authorization, as well as trends over time.
0:00 0:00 Produced in partnership with: Embed Download Volume Speed 0.5x 1x 1.25x 1.5x 2x Embed this player × <iframe src=”https://kffhealthnews.org/insurance/health-hub-kids-lose-insurance-coverage-gop-healthcare-cuts/embed/” width=”600″ height=”200″ frameborder=”0″ scrolling=”no” title=”Millions of Kids Could Lose Insurance as GOP Healthcare Cuts Start To Bite”></iframe> Copy More than 1 million children have lost insurance since President Donald Trump took office in 2025….
Harrowing scenes are unfolding at health facilities at the epicenter of an Ebola outbreak in the Democratic Republic of Congo. A 25-year-old midwife and a doctor in his early 30s are sick with Ebola symptoms, including fevers and severe joint pain, said their colleague Elisabeth Furaha, the medical director at SOFEPADI’s Karibuni Wa Mama Medical…
Having a baby in the United States is about to get more complicated. Under new billing codes that take effect in January, doctors who manage maternity care will start charging à la carte for visits and services related to pregnancy, childbirth, and postpartum care. It’s an about-face from recent years, when doctors have often received…
One Nation, Overcharged, a campaign backed by the Robert Wood Johnson Foundation, launched to raise awareness of rising healthcare costs. The post What the ‘One Nation, Overcharged’ Campaign Aims to Achieve appeared first on MedCity News.
Ona Therapeutics’ antibody drug conjugates come from a platform technology that discovers novel antigens intended to enable the therapies to overcome drug resistance. The Spain-based startup’s lead ADC is on track to begin clinical testing in breast cancer. The post Startup Secures $86M to Take On One of the Challenges for ADCs in Breast Cancer…
CereVasc raised $85 million in Series C funding to advance its minimally invasive eShunt system, which aims to treat hydrocephalus without traditional brain shunt surgery. The company is preparing for a pivotal trial completion and FDA submission in 2027. The post CereVasc Rakes In $85M to Challenge Traditional Brain Shunt Surgery appeared first on MedCity…
FDA accepts 1st In Silico Drug Development Tool.Why GLP-1’s got more affordable.BALANCE after CMS GLP-1 decision.How to socialize scientific ideas in the age of AI.Mapping the Ebola outbreak.1985-2023: MIT’s faculty grew 9%…Administrative staff grew 189%
MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, Managing Partner of Health Innovation Pitch, co-hosts of the Debunked Podcast, discussed the impact of Marty Makary’s resignation from the FDA, among other topics. The post Debunked Episode 27: The Impact of an FDA Commissioner’s Departure, Insider Trading, Microdosing GLP-1s and a Win for Lower Drug Prices…